Notice of Correction  by unknown
t
d
u
t
v
t
p
u
“
i
c
w
f
h
t
s
m
p
a
“
t
v
v
r
o
t
c
r
c
b
b
R
1
2
3
4
5
6
Harken Editorials
ED
IT
O
RI
A
Lhe right ventricular end-diastolic volume. Perhaps predictably,
onor hearts that already exhibited an increased right ventric-
lar end-diastolic volume also demonstrated early postopera-
ive dysfunction. Thus, the authors identified increased right
entricular end-diastolic volume as a predictor of postcardiac
ransplantation trouble. The authors suggest that brain death
rovokes right ventricular dysfunction and that this may go
ndetected with conventional techniques. The authors suggest
refinement of selection criteria to include load-independent
ndices of performance.” It seems that this might significantly
omplicate the evaluation of these already unstable patients. It
ould be valuable for the authors to identify “standard criteria”
or donor acceptability and then relate these criteria to pre-
arvest right ventricular volumes with an accompanying rela-
ionship between right ventricular end-diastolic volume and
uccessful cardiac function posttransplantation. The authors
ake the persuasive case that they have identified an important
redictor of donor acceptability. It would also be valuable to
ssess the number of potential donors who are acceptable by
standard criteria” and subsequently exhibit posttransplanta-
ion “trouble” that might have been predicted by the “right
entricular end-diastolic volume index.” Similarly, it would be
aluable for the authors to estimate the number of donorsdoi:10.1016/j.jtcvs.2006.05.021
The Journal of Thoracf right ventricular volume/function evaluations might identify
hem as “acceptable.”
We must admire Stoica and colleagues5 for persistently
hipping away at the intimidating complexities of the neu-
ocardiac axis. We are making progress, but our brains are
omplex. As observed by Emerson Pugh: “If the human
rain were so simple that we could understand it; we would
e so simple that we couldn’t.”
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Notices of Correction
Galetta D, Cesario A, Margaritora S, Porziella V, Piraino A, D’Angelillo RM, Gambacorta MA,
Ramella S, Trodella L, Valente S, Corbo GM, Macis G, Mulè A, Cardaci V, Sterzi S, Granone P,
Russo P. Multimodality treatment of unresectable stage III non–small cell lung cancer: Interim
analysis of a phase II trial with preoperative gemcitabine and concurrent radiotherapy. J Thorac
Cardiovasc Surg. 2006;131:314-21.
The institutional affiliation for Dr. Patrizia Russo is incorrect. Her correct affiliation is Transla-
tional Research B (Lung), Department of Integrated Medical Oncology (DOMI), National Cancer
Institute, Genova, Italy.
Bodnar E, Blackstone EH. An “actual” problem: Another issue of apples and oranges. J Thorac
Carrdiovasc Surg. 2006;131:1-3.
In the January 2006 issue of the Journal, the article contained a lengthy discussion relating to the
appropriate use of Kaplan-Meier event estimates versus use of “actual” event data. The statement that
the Journal will no longer accept articles using “actual” event rates to describe prosthesis longevity
was not meant to be included because this approach remains a source of controversy. The Journal will
allow the author’s discretion as to which event descriptor is most appropriate but reserves the right to
subject such articles to statistical review rather than applying an arbitrary standard.
J Thorac Cardiovasc Surg 2006;132:11
0022-5223/$32.00
Copyright © 2006 by The American Association for Thoracic Surgeryic and Cardiovascular Surgery ● Volume 132, Number 1 11
